The Expanding Role of Arsenic in Acute Promyelocytic LeukemiaTALLMAN, Martin S.Seminars in hematology. 2008, Vol 45, Num 3, issn 0037-1963, S25-S29, SUP2Conference Paper

Monoclonal antibody therapies in leukemiasTALLMAN, Martin S.Seminars in hematology. 2002, Vol 39, Num 4, pp 12-19, issn 0037-1963, 8 p., SUP3Article

All-trans retinoic acid in acute promyelocytic leukaemiaAVVISATI, Giuseppe; TALLMAN, Martin S.Baillière's best practice & research. Clinical haematology. 2003, Vol 16, Num 3, pp 419-432, issn 1521-6926, 14 p.Article

Acute promyelocytic leukaemiaTALLMAN, Martin S.Baillière's best practice & research. Clinical haematology. 2003, Vol 16, Num 3, issn 1521-6926, 203 p.Serial Issue

Arsenic trioxide as a selective anticancer agent: rationale and clinical utilityTALLMAN, Martin S.Seminars in hematology. 2002, Vol 39, Num 2, issn 0037-1963, 27 p., SUP1Serial Issue

Advancing the treatment of hematologic malignancies through the development of targeted interventionsTALLMAN, Martin S.Seminars in hematology. 2002, Vol 39, Num 4, issn 0037-1963, 39 p., SUP3Serial Issue

Evolving uses of Epoetin alfa and cladribine in clinical practiceTALLMAN, Martin S.Seminars in hematology. 1996, Vol 33, Num 1, issn 0037-1963, 54 p., SUP1Serial Issue

Retinoic acid syndrome: manifestations, pathogenesis, and treatmentLARSON, Richard S; TALLMAN, Martin S.Baillière's best practice & research. Clinical haematology. 2003, Vol 16, Num 3, pp 453-461, issn 1521-6926, 9 p.Article

Evolution of Targeted and Multifunctional Agents for Leukemias and LymphomasTALLMAN, Martin S.Seminars in hematology. 2008, Vol 45, Num 3, issn 0037-1963, 30 p., SUP2Conference Proceedings

Expression of cell-surface antigens in acute promyelocytic leukaemiaPAIETTA, Elisabeth.Baillière's best practice & research. Clinical haematology. 2003, Vol 16, Num 3, pp 369-385, issn 1521-6926, 17 p.Article

The epidemiology of acute promyelocytic leukaemiaDOUER, Dan.Baillière's best practice & research. Clinical haematology. 2003, Vol 16, Num 3, pp 357-367, issn 1521-6926, 11 p.Article

The scripps clinic experience with cladribine (2-CdA) in the treatment of chronic lymphocytic leukemiaSAVEN, A.Seminars in hematology. 1996, Vol 33, Num 1, pp 28-33, issn 0037-1963, SUP1Article

Established practice in the treatment of patients with acute promyleocytic leukemia and the introduction of arsenic trioxide as a novel therapyDOMBRET, Hervé; FENAUX, Pierre; SOIGNET, Steven L et al.Seminars in hematology. 2002, Vol 39, Num 2, pp 8-13, issn 0037-1963, SUP1Article

Molecular genetics of human leukemias: New insights into therapyGILLILAND, D. Gary.Seminars in hematology. 2002, Vol 39, Num 4, pp 6-11, issn 0037-1963, 6 p., SUP3Article

Epoetin alfa as a supportive measure in hematologic malignanciesSTRAUS, David J.Seminars in hematology. 2002, Vol 39, Num 4, pp 25-31, issn 0037-1963, 7 p., SUP3Article

Recombinant human erythropoietin in combination with other hematopoietic cytokines in attenuating chemotherapy-induced multilineage myelosuppression : Brief communicationVADHAN-RAJ, S.Seminars in hematology. 1996, Vol 33, Num 1, pp 16-18, issn 0037-1963, SUP1Article

Cladribine for the treatment of indolent non-Hodgkin's lymphomasHOFFMAN, M. A.Seminars in hematology. 1996, Vol 33, Num 1, pp 40-44, issn 0037-1963, SUP1Article

Remission induction in acute myeloid leukemia : PIH: How to improve the outcome of adult acute myeloid leukemia?STEIN, Eytan M; TALLMAN, Martin S.International journal of hematology. 2012, Vol 96, Num 2, pp 164-170, issn 0925-5710, 7 p.Article

Targeting FLT3 for the Treatment of LeukemiaSMALL, Donald.Seminars in hematology. 2008, Vol 45, Num 3, issn 0037-1963, S17-S21, SUP2Conference Paper

Current strategies for the treatment of diffuse large B cell lymphomaCOIFFIER, Bertrand.Current opinion in hematology. 2005, Vol 12, Num 4, pp 259-265, issn 1065-6251, 7 p.Article

FLT3-activating mutations in acute promyelocytic leukaemia: a rationale for risk-adapted therapy with FLT3 inhibitorsGILLILAND, D. Gary.Baillière's best practice & research. Clinical haematology. 2003, Vol 16, Num 3, pp 409-417, issn 1521-6926, 9 p.Article

Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemiaFALANGA, Anna; RICKLES, Frederick R.Baillière's best practice & research. Clinical haematology. 2003, Vol 16, Num 3, pp 463-482, issn 1521-6926, 20 p.Article

Treatment options for relapsed acute promyelocytic leukaemiaESTEY, Elihu H.Baillière's best practice & research. Clinical haematology. 2003, Vol 16, Num 3, pp 521-534, issn 1521-6926, 14 p.Article

How I treat acute myeloid leukemiaROWE, Jacob M; TALLMAN, Martin S.Blood. 2010, Vol 116, Num 17, pp 3147-3156, issn 0006-4971, 10 p.Article

Lymphoid biology and diseasesDINAUER, Mary C; TALLMAN, Martin S.Current opinion in hematology. 2005, Vol 12, Num 4, issn 1065-6251, 103 p.Serial Issue